Patents by Inventor Annabelle Schubert

Annabelle Schubert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220017944
    Abstract: The present invention provides methods, compositions and devices for stabilizing the extracellular nucleic acid population in a cell-containing biological sample using an apoptosis inhibitor, preferably a caspase inhibitor, a hypertonic agent and/or a compound according to formula 1 as defined in the claims.
    Type: Application
    Filed: April 29, 2021
    Publication date: January 20, 2022
    Inventors: Martin Horlitz, Annabelle Schubert, Markus Sprenger-Haussels
  • Patent number: 11021733
    Abstract: The present invention provides methods, compositions and devices for stabilizing the extracellular nucleic acid population in a cell-containing biological sample using an apoptosis inhibitor, preferably a caspase inhibitor, a hypertonic agent and/or a compound according to formula 1 as defined in the claims.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: June 1, 2021
    Assignee: Qiagen GmbH
    Inventors: Martin Horlitz, Annabelle Schubert, Markus Sprenger-Haussels
  • Patent number: 10724074
    Abstract: The present invention provides methods, compositions and devices for stabilizing the extracellular nucleic acid population in a cell-containing biological sample and for stabilizing the transcriptome of contained cells.
    Type: Grant
    Filed: September 25, 2013
    Date of Patent: July 28, 2020
    Assignee: Qiagen GmbH
    Inventors: Martin Horlitz, Annabelle Schubert, Markus Sprenger-Haussels, Kalle Günther, Ralf Wyrich, Uwe Oelmüller
  • Patent number: 10676780
    Abstract: The present invention provides methods, compositions and devices for stabilizing the extracellular nucleic acid population in a cell-containing biological sample using an apoptosis inhibitor, preferably a caspase inhibitor, a hypertonic agent and/or a compound according to formula (1) as defined in the claims.
    Type: Grant
    Filed: September 25, 2012
    Date of Patent: June 9, 2020
    Assignee: QIAGEN GMbH
    Inventors: Martin Horlitz, Annabelle Schubert, Markus Sprenger-Haussels
  • Publication number: 20200120923
    Abstract: The present invention provides methods, compositions and devices for stabilizing the extracellular nucleic acid population in a cell-containing biological sample and for stabilizing the transcriptome of contained cells.
    Type: Application
    Filed: January 6, 2020
    Publication date: April 23, 2020
    Inventors: Martin Horlitz, Annabelle Schubert, Markus Sprenger-Haussels, Kalle Günther, Ralf Wyrich, Uwe Oelmüller
  • Publication number: 20190309343
    Abstract: The present invention provides methods, compositions and devices for stabilizing the extracellular nucleic acid population in a cell-containing biological sample using an apoptosis inhibitor, preferably a caspase inhibitor, a hypertonic agent and/or a compound according to formula 1 as defined in the claims.
    Type: Application
    Filed: November 28, 2018
    Publication date: October 10, 2019
    Inventors: Martin Horlitz, Annabelle Schubert, Markus Sprenger-Haussels
  • Patent number: 10233508
    Abstract: The present disclosure provides methods, compositions and devices for isolating virus particles and/or viral nucleic acids from body samples that were stabilized using a stabilizing composition comprising a formaldehyde releaser agent.
    Type: Grant
    Filed: August 21, 2013
    Date of Patent: March 19, 2019
    Assignee: QIAGEN GmbH
    Inventors: Martin Horlitz, Markus Sprenger-Haussels, Annabelle Schubert, Uwe Oelmüller
  • Publication number: 20150275268
    Abstract: The present invention provides methods, compositions and devices for stabilizing the extracellular nucleic acid population in a cell-containing biological sample and for stabilizing the transcriptome of contained cells.
    Type: Application
    Filed: September 25, 2013
    Publication date: October 1, 2015
    Applicant: QIAGEN GmbH
    Inventors: Martin Horlitz, Annabelle Schubert, Markus Sprenger-Haussels, Kalle Günther, Ralf Wyrich, Uwe Oelmüller
  • Publication number: 20150240320
    Abstract: The present disclosure provides methods, compositions and devices for isolating virus particles and/or viral nucleic acids from body samples that were stabilized using a stabilizing composition comprising a formaldehyde releaser agent.
    Type: Application
    Filed: August 21, 2013
    Publication date: August 27, 2015
    Inventors: Martin Horlitz, Markus Sprenger-Haussels, Annabelle Schubert, Uwe Oelmüller